Table 5.
Distribution of failed samples by region and therapeutic indication
| Region/therapeutic indication | Number of samples | Number of failed samples (%) | Proportion of failed samples within the region (%) |
|---|---|---|---|
| Antimalarial | 2,517 | 222 (8.8) | 61.5 |
| Antibiotic | 400 | 10 (2.5) | 2.8 |
| Antituberculosis | 74 | 49 (66.2) | 13.6 |
| Antiretroviral | NA | 33 | NA |
| Others | 307 | 47 (15.3) | 13.0 |
| Total Africa | 3,371 | 361 (10.7) | 100 |
| Antimalarial | 4,321 | 249 (5.76) | 66.1 |
| Antibiotic | 4,473 | 77 (1.7) | 20.4 |
| Antituberculosis | 1,616 | 37 (2.3) | 9.8 |
| Antiretroviral | 251 | 2 (0.8) | 0.5 |
| Other | 76 | 12 (15.8) | 3.2 |
| Total Asia | 10,737 | 377 (3.5) | 100 |
| Antimalarial | 495 | 7 (1.4) | 6.3 |
| Antibiotic | 301 | 63 (20.9) | 57.3 |
| Antituberculosis | 59 | 9 (15.3) | 8.2 |
| Other | 100 | 31 (31.0) | 28.2 |
| Total South America | 955 | 110 (11.5) | 100 |
| Total | 15,063 | 848 | 5.6 |
Regional proportion of failure is calculated using the number of failed samples for a therapeutic indication in a region as a percent of the total number of failed samples in the therapeutic indication.